| DRMA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the DRMA shares outstanding history going back to 11/10/2021:
Also see: DRMA Market Cap History DRMA YTD Return |
DRMA Shares Outstanding History — Dermata Therapeutics Share Count Over Time
As of 3/25/2026 Dermata Therapeutics has 4.02 million DRMA shares outstanding. Investors often track the DRMA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DRMA share count trends over time, with 18 historical shares outstanding datapoints presented, dating back to 11/10/2021.
| DRMA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||
DRMA Historical Shares Outstanding: +402.57% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| DRMA Stock Price Chart |
| About Dermata Therapeutics Inc |
| Dermata Therapeutics, Inc. is a late-stage medical dermatology company. Co. is focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, both incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its lead product candidate, DMT310, is intended to utilize its Spongilla technology for once weekly treatment of a variety of skin diseases, with its initial focus being the treatment of acne vulgaris, which has a U.S. market size of approximately 50 million patients. We show 18 historical shares outstanding datapoints in our coverage of DRMA's shares outstanding history. Understanding the changing numbers of DRMA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DRMA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DRMA by allowing them to research DRMA shares outstanding history as well as any other stock in our coverage universe. |
| DRMA Current Stock Quote |
Quotes delayed 20 minutes  Free DRMA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DRMA Share Performance |
| Shares Outstanding Peers |
| Dermata Therapeutics (DRMA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DRNA Shares Outstanding History DRRX Shares Outstanding History DSGN Shares Outstanding History DTIL Shares Outstanding History DVA Shares Outstanding History DVAX Shares Outstanding History DVCR Shares Outstanding History DWTX Shares Outstanding History DXCM Shares Outstanding History DYAI Shares Outstanding History More Healthcare companies » |
DRMA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
